Price gains in the TecDAX index: These stocks are currently increasing

Transparenz: Redaktionell erstellt und geprüft.
Veröffentlicht am

According to a report by m.ariva.de, the TecDAX index is currently recording slight price gains, which can be attributed to the positive sentiment of private and institutional investors on the German stock market. The index rose by 1.21 percent to 3,389 points. These stocks can currently increase. The securities from MorphoSys, Qiagen NV and Evotec currently lead the index rankings, with the biggest increase being recorded by the MorphoSys security. The share price rose by 13.17 percent, while investors are currently paying 64.96 euros for the paper on the stock exchange. MorphoSys AG is engaged in the discovery, development and marketing of therapeutic antibodies and...

Gemäß einem Bericht von m.ariva.de, verzeichnet der TecDAX-Index derzeit leichte Kursgewinne, die auf die positiven Stimmungen der privaten und institutionellen Investoren am deutschen Aktienmarkt zurückzuführen sind. Der Index stieg um 1,21 Prozent auf 3.389 Punkte. Diese Aktien können aktuell zulegen Aktuell führen die Papiere von MorphoSys, Qiagen NV und Evotec die Indexrangliste an, wobei das größte Plus bei dem Wertpapier von MorphoSys zu verzeichnen ist. Der Kurs der Aktie stieg um 13,17 Prozent, während Investoren derzeit 64,96 Euro an der Börse für das Papier zahlen. Die MorphoSys AG beschäftigt sich mit der Entdeckung, Entwicklung und Vermarktung von therapeutischen Antikörpern und …
According to a report by m.ariva.de, the TecDAX index is currently recording slight price gains, which can be attributed to the positive sentiment of private and institutional investors on the German stock market. The index rose by 1.21 percent to 3,389 points. These stocks can currently increase. The securities from MorphoSys, Qiagen NV and Evotec currently lead the index rankings, with the biggest increase being recorded by the MorphoSys security. The share price rose by 13.17 percent, while investors are currently paying 64.96 euros for the paper on the stock exchange. MorphoSys AG is engaged in the discovery, development and marketing of therapeutic antibodies and...

Price gains in the TecDAX index: These stocks are currently increasing

According to a report by m.ariva.de, the TecDAX index is currently recording slight price gains, which can be attributed to the positive sentiment of private and institutional investors on the German stock market. The index rose by 1.21 percent to 3,389 points.

These stocks can currently rise

The securities from MorphoSys, Qiagen NV and Evotec currently lead the index rankings, with the biggest increase being recorded by the MorphoSys security. The share price rose by 13.17 percent, while investors are currently paying 64.96 euros for the paper on the stock exchange. MorphoSys AG is engaged in the discovery, development and marketing of therapeutic antibodies and has focused on the treatment of cancer and autoimmune diseases in the USA. Qiagen NV shares also recorded a price increase of 6.06 percent to 41.94 euros, while Evotec shares rose by 5.17 percent to 13.94 euros.

The losers of the trading day

At the end of the TecDAX price list are currently the stocks from Infineon, Aixtron and Freenet. Infineon recorded a price decline of 3.42 percent to 33.47 euros, followed by Aixtron with a decline of 2.74 percent to 32.68 euros and Freenet with a discount of 1.78 percent to 24.28 euros.

So far the TecDAX index has gained 1.54 percent this year. The 30 technology stocks that follow the 40 DAX companies in terms of market capitalization and stock exchange turnover are included in the TecDAX by Deutsche Börse.

The positive price developments of MorphoSys, Qiagen NV and Evotec show that investors have confidence in the technology stocks. This development could continue to strengthen interest in technology stocks and have a positive impact on the TecDAX index and the financial industry.

Read the source article at m.ariva.de

To the article